Humana (NYSE:HUM) PT Lowered to $381.00

Humana (NYSE:HUM) had its price target cut by Jefferies Financial Group from $411.00 to $381.00 in a research report released on Monday, Benzinga reports. They currently have a buy rating on the insurance provider’s stock.

A number of other brokerages have also weighed in on HUM. The Goldman Sachs Group decreased their price objective on shares of Humana from $450.00 to $385.00 and set a buy rating for the company in a report on Wednesday, April 3rd. Barclays decreased their target price on shares of Humana from $356.00 to $310.00 and set an equal weight rating for the company in a research note on Tuesday, April 2nd. Wells Fargo & Company decreased their target price on shares of Humana from $413.00 to $350.00 and set an overweight rating for the company in a research note on Monday, April 8th. Deutsche Bank Aktiengesellschaft lowered shares of Humana from a buy rating to a hold rating and decreased their target price for the company from $595.00 to $360.00 in a research note on Thursday, January 25th. Finally, Bank of America reiterated a neutral rating and set a $342.00 target price (down from $470.00) on shares of Humana in a research note on Tuesday, April 2nd. Eleven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of Hold and a consensus price target of $454.63.

Humana Price Performance

Shares of NYSE HUM opened at $316.04 on Monday. Humana has a twelve month low of $299.23 and a twelve month high of $541.21. The firm has a market cap of $38.13 billion, a P/E ratio of 15.95, a PEG ratio of 1.91 and a beta of 0.45. The company has a 50 day moving average of $329.24 and a 200 day moving average of $396.94. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.63.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. Humana had a net margin of 2.34% and a return on equity of 19.44%. The company had revenue of $29.61 billion during the quarter, compared to analyst estimates of $28.52 billion. During the same period in the previous year, the business earned $9.38 EPS. The firm’s revenue for the quarter was up 10.7% on a year-over-year basis. As a group, research analysts expect that Humana will post 16.06 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.12%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio is currently 17.86%.

Insider Buying and Selling

In other news, Director Jorge S. Mesquita bought 545 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was bought at an average price of $367.09 per share, with a total value of $200,064.05. Following the acquisition, the director now owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.29% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Mariner LLC boosted its holdings in Humana by 2.3% in the 3rd quarter. Mariner LLC now owns 14,119 shares of the insurance provider’s stock worth $6,869,000 after buying an additional 312 shares during the period. Massachusetts Financial Services Co. MA lifted its stake in Humana by 27.5% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 27,943 shares of the insurance provider’s stock worth $13,595,000 after purchasing an additional 6,034 shares in the last quarter. Silverarc Capital Management LLC purchased a new stake in Humana in the 3rd quarter worth $4,865,000. Vest Financial LLC lifted its stake in Humana by 43.3% in the 4th quarter. Vest Financial LLC now owns 27,993 shares of the insurance provider’s stock worth $12,815,000 after purchasing an additional 8,455 shares in the last quarter. Finally, Artemis Investment Management LLP lifted its stake in Humana by 9.6% in the 4th quarter. Artemis Investment Management LLP now owns 64,573 shares of the insurance provider’s stock worth $29,563,000 after purchasing an additional 5,672 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.